Metpri GP 2mg/500mg/15mg Tablet
Marketer
Atlantis Formulations Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metpri GP 2mg/500mg/15mg Tablet
Metpri GP 2mg/500mg/15mg tablets combine medications to effectively manage blood glucose. This regimen, used alongside diet and exercise, enhances blood sugar regulation in adult patients with type 2 diabetes. It facilitates efficient insulin use, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and duration for Metpri GP 2mg/500mg/15mg tablets. Ingestion with food minimizes stomach discomfort. Missed doses should be taken promptly, unless nearing the next scheduled dose; in such cases, omit the missed dose and resume your usual schedule. Never double the dose. Excessive intake can trigger hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor about any kidney, liver, or heart conditions. Pregnant or lactating individuals should seek medical counsel before use. Kidney function tests are typically conducted before initiating therapy. Limit alcohol consumption as it may heighten the risk of side effects.
Primary Ingredients of Metpri GP 2mg/500mg/15mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Metpri GP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Metpri GP 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metpri GP 2mg/500mg/15mg tablet whole; do not bite, pulverize, or fracture it. Administer this medication with food.
Common Side effects of Metpri GP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metpri GP 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metpri GP 2mg/500mg/15mg Tablet whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with food.
How Metpri GP 2mg/500mg/15mg Tablet works:
Metpri GP tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions—to enhance blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Metpri GP 2mg/500mg/15mg tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Use of Metpri GP 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Metpri GP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Metpri GP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. The use of Metpri GP 2mg/500mg/15mg tablets is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Metpri GP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Metpri GP 2mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Metpri GP 2mg/500mg/15mg Tablet :
Should you forget to take your Metpri GP 2mg/500mg/15mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metpri GP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently